glp-2 vs glp-1 vs. vs. GLP-3: Know the Difference Not all GLP therapies are the same — and choosing the wrong one is one of the most common mistakes we see. GLP-1: Targets GLP-1-based therapies for type 2

Physiology of the weight-loss plateau in response to diet restriction, GLP-1 receptor agonism and bariatric surgery

Insulin treatment prevents the increase in D-serine in hippocampal CA1 area of diabetic rats

Furthermore, in January 2025, the FDA approved semaglutide (Ozempic ) for reducing the risk of kidney failure and disease progression in patients with diabetes and chronic kidney disease (CKD), making it the first GLP-1 agent indicated for the treatment of CKD (Perkovic et al., 2024)

[DOI] [PMC free article] [PubMed] [Google Scholar] 28.Valverde I., Rigopoulou D., Exton J., Ohneda A., Eisentraut A., Unger R.H

What Are the Ingredients in GLP-1 Up

These apply to everyone, but they become especially important when semaglutide side effects create additional vulnerability